238 related articles for article (PubMed ID: 11401583)
21. Lactoferrin, a potent tryptase inhibitor, abolishes late-phase airway responses in allergic sheep.
Elrod KC; Moore WR; Abraham WM; Tanaka RD
Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):375-81. PubMed ID: 9279212
[TBL] [Abstract][Full Text] [Related]
22. Human beta-tryptase: detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors.
Fukuoka Y; Schwartz LB
Biochemistry; 2004 Aug; 43(33):10757-64. PubMed ID: 15311937
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of human mast cell tryptase by benzamidine derivatives.
Stürzebecher J; Prasa D; Sommerhoff CP
Biol Chem Hoppe Seyler; 1992 Oct; 373(10):1025-30. PubMed ID: 1418674
[TBL] [Abstract][Full Text] [Related]
24. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts.
Schechter NM; Brass LF; Lavker RM; Jensen PJ
J Cell Physiol; 1998 Aug; 176(2):365-73. PubMed ID: 9648924
[TBL] [Abstract][Full Text] [Related]
25. Guinea pig lung tryptase. Localisation to mast cells and characterisation of the partially purified enzyme.
McEuen AR; He S; Brander ML; Walls AF
Biochem Pharmacol; 1996 Jul; 52(2):331-40. PubMed ID: 8694858
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneous effects of protamine on human mast cells and basophils.
Patella V; Ciccarelli A; Lamparter-Schummert B; de Paulis A; Adt M; Marone G
Br J Anaesth; 1997 Jun; 78(6):724-30. PubMed ID: 9215027
[TBL] [Abstract][Full Text] [Related]
27. Enzyme histochemistry of tryptase in stomach mucosal mast cells of the mouse.
Valchanov KP; Proctor GB
J Histochem Cytochem; 1999 May; 47(5):617-22. PubMed ID: 10219054
[TBL] [Abstract][Full Text] [Related]
28. Biology of mast cell tryptase. An inflammatory mediator.
Hallgren J; Pejler G
FEBS J; 2006 May; 273(9):1871-95. PubMed ID: 16640553
[TBL] [Abstract][Full Text] [Related]
29. Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone.
Costanzo MJ; Yabut SC; Almond HR; Andrade-Gordon P; Corcoran TW; De Garavilla L; Kauffman JA; Abraham WM; Recacha R; Chattopadhyay D; Maryanoff BE
J Med Chem; 2003 Aug; 46(18):3865-76. PubMed ID: 12930148
[TBL] [Abstract][Full Text] [Related]
30. Role of tryptase in immediate cutaneous responses in allergic sheep.
Molinari JF; Moore WR; Clark J; Tanaka R; Butterfield JH; Abraham WM
J Appl Physiol (1985); 1995 Dec; 79(6):1966-70. PubMed ID: 8847261
[TBL] [Abstract][Full Text] [Related]
31. The B12 anti-tryptase monoclonal antibody disrupts the tetrameric structure of heparin-stabilized beta-tryptase to form monomers that are inactive at neutral pH and active at acidic pH.
Fukuoka Y; Schwartz LB
J Immunol; 2006 Mar; 176(5):3165-72. PubMed ID: 16493076
[TBL] [Abstract][Full Text] [Related]
32. Modulation of enzymatic activity of human mast cell tryptase and chymase by protease inhibitors.
He SH; Chen P; Chen HQ
Acta Pharmacol Sin; 2003 Sep; 24(9):923-9. PubMed ID: 12956943
[TBL] [Abstract][Full Text] [Related]
33. [Effect of tryptase inhibitors on histamine release from human colon mast cells].
Xie H; He SH; Cheng MH; Fu YL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):678-81. PubMed ID: 15555433
[TBL] [Abstract][Full Text] [Related]
34. Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug.
Erba F; Fiorucci L; Pascarella S; Menegatti E; Ascenzi P; Ascoli F
Biochem Pharmacol; 2001 Feb; 61(3):271-6. PubMed ID: 11172730
[TBL] [Abstract][Full Text] [Related]
35. Structural changes associated with the spontaneous inactivation of the serine proteinase human tryptase.
Schechter NM; Eng GY; Selwood T; McCaslin DR
Biochemistry; 1995 Aug; 34(33):10628-38. PubMed ID: 7654717
[TBL] [Abstract][Full Text] [Related]
36. Human beta-tryptase is a ring-like tetramer with active sites facing a central pore.
Pereira PJ; Bergner A; Macedo-Ribeiro S; Huber R; Matschiner G; Fritz H; Sommerhoff CP; Bode W
Nature; 1998 Mar; 392(6673):306-11. PubMed ID: 9521329
[TBL] [Abstract][Full Text] [Related]
37. Mast cell chymase in complex with heparin proteoglycan is regulated by protamine.
Pejler G
FEBS Lett; 1996 Apr; 383(3):170-4. PubMed ID: 8925890
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase.
Jackson DS; Fraser SA; Ni LM; Kam CM; Winkler U; Johnson DA; Froelich CJ; Hudig D; Powers JC
J Med Chem; 1998 Jun; 41(13):2289-301. PubMed ID: 9632362
[TBL] [Abstract][Full Text] [Related]
39. Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: characterization of the binding of heparin to lactoferrin.
Pejler G
Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):897-903. PubMed ID: 9003378
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of tryptase release from human colon mast cells by histamine receptor antagonists.
He SH; Xie H; Fu YL
Asian Pac J Allergy Immunol; 2005 Mar; 23(1):35-9. PubMed ID: 15997873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
